Increased antimicrobial resistance during the COVID-19 pandemic

CC Lai, SY Chen, WC Ko, PR Hsueh - International journal of antimicrobial …, 2021 - Elsevier
In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection
itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the …

COVID-19 and tuberculosis coinfection: an overview of case reports/case series and meta-analysis

W Song, J Zhao, Q Zhang, S Liu, X Zhu, Q An… - Frontiers in …, 2021 - frontiersin.org
Background: Coronavirus disease 2019 (COVID-19) and tuberculosis (TB) are two major
infectious diseases posing significant public health threats, and their coinfection (aptly …

Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021)

Q Wang, S Guo, X Wei, Q Dong, N Xu, H Li, J Zhao… - BMJ open, 2022 - bmjopen.bmj.com
Introduction The COVID-19 outbreak poses a significant threat to the patients with
tuberculosis (TB). TB and COVID-19 (TB–COVID) coinfection means the disease caused by …

Pulmonary cavitation: an under-recognized late complication of severe COVID-19 lung disease

Z Zoumot, MF Bonilla, AS Wahla, I Shafiq… - BMC Pulmonary …, 2021 - Springer
Background Pulmonary radiological findings of the novel coronavirus disease 2019 (COVID-
19) have been well documented and range from scattered ground-glass infiltrates in milder …

COVID-19 and tuberculosis coinfection: An overview of case reports/case series and meta-analysis of prevalence studies

P Daneshvar, B Hajikhani, F Sameni, N Noorisepehr… - Heliyon, 2023 - cell.com
Background and aim Coronavirus disease 2019 (COVID-19) coinfection with other
respiratory pathogens poses a serious concern that can complicate diagnosis, treatment …

Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection

T Shah, Z Shah, N Yasmeen, Z Baloch… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, is an infectious disease
that poses severe threats to global public health and significant economic losses. The …

Mycobacterium tuberculosis and SARS-CoV-2 Coinfections: A Review

N Bostanghadiri, FM Jazi, S Razavi, L Fattorini… - Frontiers in …, 2022 - frontiersin.org
Background Tuberculosis (TB) is still one of the most important causes of death worldwide.
The lack of timely attention on TB diagnosis and treatment during the coronavirus disease …

The impact of the COVID-19 pandemic on antimicrobial resistance and management of bloodstream infections

V Petrakis, M Panopoulou, P Rafailidis, N Lemonakis… - Pathogens, 2023 - mdpi.com
Introduction: The pressure of the COVID-19 pandemic on healthcare systems led to limited
roles of infectious diseases services, increased rates of irrational use of antimicrobials, and …

Clinical features and treatment outcome of coronavirus and tuberculosis co-infected patients: a systematic review of case reports

H Mollalign, D Chala, D Beyene - Infection and Drug Resistance, 2022 - Taylor & Francis
Background Coronavirus disease 19 (COVID-19) and Mycobacterium tuberculosis (MTB)
are among the top ongoing health crises globally. Both cause respiratory diseases, and the …

Clinical outcomes of individuals with COVID-19 and tuberculosis during the pre-vaccination period of the pandemic: A systematic review

TA Jhaveri, C Fung, AN LaHood, A Lindeborg… - Journal of Clinical …, 2022 - mdpi.com
Background: Tuberculosis, like COVID-19, is most often a pulmonary disease. The COVID-
19 pandemic has severely disrupted tuberculosis services in myriad ways: health facility …